Advanced Search (OLGA)

Gene: Gm18870 (predicted gene, 18870) Mus musculus

Subscribe to Updates

Analyze

Symbol:

Gm18870

Name:

predicted gene, 18870

RGD ID:

5142684

MGI Page

MGI

Description:

Type:

pseudo (Ensembl: lncRNA)

RefSeq Status:

INFERRED

Related Functional Gene:

Zscan5b

Latest Assembly:

GRCm39 - Mouse Genome Assembly GRCm39

Position:

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	16	62,825,825 - 62,827,142 (+)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	16	62,823,671 - 62,928,885 (+)	Ensembl		GRCm39 Ensembl
GRCm38	16	63,005,462 - 63,006,779 (+)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	16	63,003,438 - 63,108,522 (+)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	16	63,005,288 - 63,006,605 (+)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
Celera	16	63,313,637 - 63,314,954 (+)	NCBI		Celera
Cytogenetic Map	16	C1.3	NCBI
cM Map	16	36.47	NCBI

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Variants in Gm18870
49 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 16p13.11-12.1(chr16:14954894-28306843)x3	copy number gain	See cases [RCV000051828]	Chr16:14954894..28306843 [GRCh38] Chr16:15048751..28318164 [GRCh37] Chr16:14956252..28225665 [NCBI36] Chr16:16p13.11-12.1	pathogenic
GRCh38/hg38 16p12.2-11.2(chr16:21463739-29249579)x3	copy number gain	See cases [RCV000051829]	Chr16:21463739..29249579 [GRCh38] Chr16:21475060..29260900 [GRCh37] Chr16:21382561..29168401 [NCBI36] Chr16:16p12.2-11.2	pathogenic
GRCh38/hg38 16p12.2-11.2(chr16:21602183-29314373)x3	copy number gain	See cases [RCV000051842]	Chr16:21602183..29314373 [GRCh38] Chr16:21613504..29325694 [GRCh37] Chr16:21521005..29233195 [NCBI36] Chr16:16p12.2-11.2	pathogenic
GRCh38/hg38 16p12.2-11.2(chr16:23047969-30632245)x3	copy number gain	See cases [RCV000052401]	Chr16:23047969..30632245 [GRCh38] Chr16:23059290..30643566 [GRCh37] Chr16:22966791..30551067 [NCBI36] Chr16:16p12.2-11.2	pathogenic
GRCh38/hg38 16p12.2-12.1(chr16:21600992-28323344)x1	copy number loss	See cases [RCV000052519]	Chr16:21600992..28323344 [GRCh38] Chr16:21612313..28334665 [GRCh37] Chr16:21519814..28242166 [NCBI36] Chr16:16p12.2-12.1	pathogenic
GRCh38/hg38 16p13.3-11.2(chr16:4644892-29170820)x3	copy number gain	See cases [RCV000133809]	Chr16:4644892..29170820 [GRCh38] Chr16:4694893..29182141 [GRCh37] Chr16:4634894..29089642 [NCBI36] Chr16:16p13.3-11.2	pathogenic
GRCh38/hg38 16p12.2-11.2(chr16:22634385-29227323)x3	copy number gain	See cases [RCV000135594]	Chr16:22634385..29227323 [GRCh38] Chr16:22645706..29238644 [GRCh37] Chr16:22553207..29146145 [NCBI36] Chr16:16p12.2-11.2	likely pathogenic
GRCh38/hg38 16p12.2-11.2(chr16:21350622-29202837)x3	copy number gain	See cases [RCV000140235]	Chr16:21350622..29202837 [GRCh38] Chr16:21361943..29214158 [GRCh37] Chr16:21269444..29121659 [NCBI36] Chr16:16p12.2-11.2	likely pathogenic
GRCh37/hg19 16p13.3-11.2(chr16:102839-28327676)x3	copy number gain	See cases [RCV000203445]	Chr16:102839..28327676 [GRCh37] Chr16:16p13.3-11.2	pathogenic
GRCh37/hg19 16p12.3-11.2(chr16:19590412-29814175)x3	copy number gain	Breast ductal adenocarcinoma [RCV000207226]	Chr16:19590412..29814175 [GRCh37] Chr16:16p12.3-11.2	uncertain significance
GRCh37/hg19 16p13.3-11.2(chr16:1279324-31926800)x3	copy number gain	Breast ductal adenocarcinoma [RCV000207053]	Chr16:1279324..31926800 [GRCh37] Chr16:16p13.3-11.2	uncertain significance
GRCh37/hg19 16p12.2-11.2(chr16:21475039-29043958)x1	copy number loss	Chromosome 16p12.2-p11.2 deletion syndrome [RCV003315282]	Chr16:21475039..29043958 [GRCh37] Chr16:16p12.2-11.2	pathogenic
GRCh37/hg19 16p12.3-11.2(chr16:19424115-30142220)x3	copy number gain	See cases [RCV000449403]	Chr16:19424115..30142220 [GRCh37] Chr16:16p12.3-11.2	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3	copy number gain	See cases [RCV000446684]	Chr16:69193..90274381 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16p12.2(chr16:23567993-23666408)x1	copy number loss	See cases [RCV000447156]	Chr16:23567993..23666408 [GRCh37] Chr16:16p12.2	uncertain significance
GRCh37/hg19 16p13.2-q24.3(chr16:9273328-89548493)x3	copy number gain	See cases [RCV000511622]	Chr16:9273328..89548493 [GRCh37] Chr16:16p13.2-q24.3	uncertain significance
GRCh37/hg19 16p12.2-11.2(chr16:22718350-28858721)x4	copy number gain	See cases [RCV000511587]	Chr16:22718350..28858721 [GRCh37] Chr16:16p12.2-11.2	pathogenic
GRCh37/hg19 16p12.2-11.2(chr16:21596299-30399167)x1	copy number loss	See cases [RCV000511271]	Chr16:21596299..30399167 [GRCh37] Chr16:16p12.2-11.2	pathogenic
maternal UPD(16p)	complex	Hemimegalencephaly [RCV000494707]	Chr16:1280042..33710558 [GRCh37] Chr16:16p13.3-11.2	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)	copy number gain	See cases [RCV000511296]	Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3	copy number gain	See cases [RCV000512138]	Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16p12.3-11.2(chr16:18238275-30177240)x3	copy number gain	See cases [RCV000512428]	Chr16:18238275..30177240 [GRCh37] Chr16:16p12.3-11.2	pathogenic
GRCh37/hg19 16p12.2-11.2(chr16:21379628-29351826)x3	copy number gain	See cases [RCV000512478]	Chr16:21379628..29351826 [GRCh37] Chr16:16p12.2-11.2	pathogenic
GRCh37/hg19 16p12.2-11.2(chr16:21379628-29379768)x1	copy number loss	not provided [RCV000683786]	Chr16:21379628..29379768 [GRCh37] Chr16:16p12.2-11.2	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3	copy number gain	not provided [RCV000738918]	Chr16:88165..90274695 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3	copy number gain	not provided [RCV000738915]	Chr16:61451..90294632 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3	copy number gain	not provided [RCV000738917]	Chr16:88165..90163275 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
NM_005003.3(NDUFAB1):c.40C>T (p.Pro14Ser)	single nucleotide variant	not provided [RCV000895425]	Chr16:23596251 [GRCh38] Chr16:23607572 [GRCh37] Chr16:16p12.2	benign
NC_000016.9:g.21530207_29332245del	deletion	not provided [RCV001030428]	Chr16:21530207..29332245 [GRCh37] Chr16:16p12.2-11.2	pathogenic
NM_005003.3(NDUFAB1):c.442A>G (p.Ile148Val)	single nucleotide variant	not specified [RCV004306891]	Chr16:23582313 [GRCh38] Chr16:23593634 [GRCh37] Chr16:16p12.2	uncertain significance
GRCh37/hg19 16p12.2-11.2(chr16:21312200-29646379)x3	copy number gain	not provided [RCV001249228]	Chr16:21312200..29646379 [GRCh37] Chr16:16p12.2-11.2	not provided
NM_005003.3(NDUFAB1):c.225G>A (p.Thr75=)	single nucleotide variant	not provided [RCV000891160]	Chr16:23587263 [GRCh38] Chr16:23598584 [GRCh37] Chr16:16p12.2	benign
GRCh37/hg19 16p13.3-11.2(chr16:4380767-30445350)x3	copy number gain	not provided [RCV002472599]	Chr16:4380767..30445350 [GRCh37] Chr16:16p13.3-11.2	pathogenic
GRCh37/hg19 16p12.2-11.2(chr16:21576802-29351826)x3	copy number gain	not provided [RCV001006786]	Chr16:21576802..29351826 [GRCh37] Chr16:16p12.2-11.2	pathogenic
GRCh37/hg19 16p13.3-11.2(chr16:5805001-34230001)	copy number gain	Microcephaly [RCV001252948]	Chr16:5805001..34230001 [GRCh37] Chr16:16p13.3-11.2	pathogenic
GRCh37/hg19 16p13.3-11.2(chr16:2959279-30190593)x3	copy number gain	See cases [RCV001263169]	Chr16:2959279..30190593 [GRCh37] Chr16:16p13.3-11.2	pathogenic\|likely pathogenic
GRCh37/hg19 16p12.2-11.2(chr16:21594997-29625302)x1	copy number loss	not provided [RCV001795549]	Chr16:21594997..29625302 [GRCh37] Chr16:16p12.2-11.2	pathogenic
NC_000016.9:g.(?_23464127)_(23635435_?)del	deletion	not provided [RCV001951393]	Chr16:23464127..23635435 [GRCh37] Chr16:16p12.2	pathogenic
NC_000016.9:g.(?_23193865)_(23652612_?)del	deletion	COG7 congenital disorder of glycosylation [RCV003113761]	Chr16:23193865..23652612 [GRCh37] Chr16:16p12.2	uncertain significance
NC_000016.9:g.(?_23543958)_(23619353_?)del	deletion	not provided [RCV003122502]	Chr16:23543958..23619353 [GRCh37] Chr16:16p12.2	pathogenic
NC_000016.9:g.(?_23584033)_(23647150_?)del	deletion	Familial cancer of breast [RCV003122698]	Chr16:23584033..23647150 [GRCh37] Chr16:16p12.2	pathogenic
GRCh37/hg19 16p12.2-11.2(chr16:21576803-30177240)x3	copy number gain	not provided [RCV002474541]	Chr16:21576803..30177240 [GRCh37] Chr16:16p12.2-11.2	pathogenic
NM_005003.3(NDUFAB1):c.196C>T (p.Arg66Cys)	single nucleotide variant	not specified [RCV004205713]	Chr16:23587292 [GRCh38] Chr16:23598613 [GRCh37] Chr16:16p12.2	uncertain significance
NM_005003.3(NDUFAB1):c.91C>A (p.Pro31Thr)	single nucleotide variant	not specified [RCV004234171]	Chr16:23596200 [GRCh38] Chr16:23607521 [GRCh37] Chr16:16p12.2	uncertain significance
NM_005003.3(NDUFAB1):c.289A>G (p.Lys97Glu)	single nucleotide variant	not specified [RCV004167207]	Chr16:23587199 [GRCh38] Chr16:23598520 [GRCh37] Chr16:16p12.2	uncertain significance
NM_005003.3(NDUFAB1):c.16C>T (p.Leu6Phe)	single nucleotide variant	not specified [RCV004231805]	Chr16:23596275 [GRCh38] Chr16:23607596 [GRCh37] Chr16:16p12.2	uncertain significance
NM_005003.3(NDUFAB1):c.106C>G (p.Leu36Val)	single nucleotide variant	not specified [RCV004072731]	Chr16:23596185 [GRCh38] Chr16:23607506 [GRCh37] Chr16:16p12.2	uncertain significance
NM_005003.3(NDUFAB1):c.245G>A (p.Arg82His)	single nucleotide variant	not specified [RCV004350579]	Chr16:23587243 [GRCh38] Chr16:23598564 [GRCh37] Chr16:16p12.2	uncertain significance
NM_005003.3(NDUFAB1):c.37C>G (p.Leu13Val)	single nucleotide variant	not specified [RCV004484662]	Chr16:23596254 [GRCh38] Chr16:23607575 [GRCh37] Chr16:16p12.2	uncertain significance
NM_005003.3(NDUFAB1):c.65G>T (p.Arg22Leu)	single nucleotide variant	not specified [RCV004484668]	Chr16:23596226 [GRCh38] Chr16:23607547 [GRCh37] Chr16:16p12.2	uncertain significance
NM_005003.3(NDUFAB1):c.99C>A (p.Ser33Arg)	single nucleotide variant	not specified [RCV004484676]	Chr16:23596192 [GRCh38] Chr16:23607513 [GRCh37] Chr16:16p12.2	uncertain significance
NC_000016.9:g.(?_23605874)_(23640542_?)del	deletion	Familial cancer of breast [RCV004581596]	Chr16:23605874..23640542 [GRCh37] Chr16:16p12.2	pathogenic
GRCh37/hg19 16p12.2(chr16:22920852-24124026)x3	copy number gain	not provided [RCV004819623]	Chr16:22920852..24124026 [GRCh37] Chr16:16p12.2	uncertain significance
NM_005003.3(NDUFAB1):c.411G>C (p.Lys137Asn)	single nucleotide variant	not specified [RCV004829534]	Chr16:23582344 [GRCh38] Chr16:23593665 [GRCh37] Chr16:16p12.2	uncertain significance
NM_005003.3(NDUFAB1):c.419G>A (p.Cys140Tyr)	single nucleotide variant	not specified [RCV004829533]	Chr16:23582336 [GRCh38] Chr16:23593657 [GRCh37] Chr16:16p12.2	uncertain significance

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
1301138	Pcd4ts3_m	p-glycoprotein positive CD4 T cell subset 3 (mouse)			Not determined		16	40593923	74594076	Mouse
1301394	Eae11_m	susceptibility to experimental allergic encephalomyelitis 11 (mouse)			Not determined		16	53561891	87562035	Mouse
26884376	Skwq4_m	skull length QTL 4, 5 week (mouse)					16	8417864	90896888	Mouse
1302096	Aod1a_m	autoimmune ovarian dysgenesis 1a (mouse)			Not determined		16	35446643	92573008	Mouse
4141212	Imraq3_m	immune response to AAV2 QTL 3 (mouse)			Not determined		16	44383350	78383506	Mouse
1558836	Dice1b_m	determination of interleukin 4 commitment 1b (mouse)			Not determined		16	45511000	72274485	Mouse
1301719	Remslp3_m	rapid eye movement sleep 3 (mouse)			Not determined		16	44383350	78383506	Mouse
1357778	Diobq_m	diet-induced obesity QTL (mouse)			Not determined		16	42197817	82331174	Mouse
1301364	Lith14_m	lithogenic gene 14 (mouse)			Not determined		16	55661846	89661961	Mouse
26884432	Zlq7_m	zygomatic length QTL 7, 10 week (mouse)					16	3817864	64620363	Mouse
4142187	Arrd3_m	age-related retinal degeneration 3 (mouse)			Not determined			32522909	65466552	Mouse
11522747	Eae41_m	experimental allergic encephalomyelitis susceptibility 41 (mouse)					16	40399134	78015472	Mouse
14928310	Manh80_m	mandible shape 80 (mouse)					16	48219841	82219841	Mouse
1301125	Sluc27_m	susceptibility to lung cancer 27 (mouse)			Not determined		16	61608644	95608764	Mouse
1357763	Lp1_m	lymphocyte proliferation 1 (mouse)			Not determined		16	6542979	65466552	Mouse
1357517	Bwtn1_m	body weight at necropsy 1 (mouse)			Not determined		16	20019329	85600826	Mouse
26884416	Bzwq5_m	bi-zygomatic width QTL 5, 5 week (mouse)					16	37320362	84696888	Mouse
1301070	Cypr1_m	cytokine production 1 (mouse)			Not determined		16	32312795	66312933	Mouse
27226785	Feml12_m	femur length 12, 5 week (mouse)					16	3317864	64620363	Mouse
4142112	Skts-fp3_m	skin tumor susceptibility in FVB and PWK 3 (mouse)			Not determined		16	40053881	72924385	Mouse

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.


RefSeq Transcripts	NG_017786	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AC163285	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENSMUST00000231727

Type:

CODING

Position:

Mouse Assembly	Chr	Position (strand)	Source
GRCm39 Ensembl	16	62,823,801 - 62,928,885 (+)	Ensembl
GRCm38.p6 Ensembl	16	63,003,438 - 63,108,522 (+)	Ensembl

Ensembl Acc Id:

ENSMUST00000281270

Type:

CODING

Position:

Mouse Assembly	Chr	Position (strand)	Source
GRCm39 Ensembl	16	62,823,671 - 62,826,761 (+)	Ensembl

Database	Acc Id	Source(s)
Ensembl Genes	ENSMUSG00000116574	Ensembl
MGD	MGI:5011055	ENTREZGENE
NCBI Gene	100417865	ENTREZGENE
PhenoGen	Gm18870	PhenoGen
RNAcentral	URS0000D70A28	RNACentral

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Send us a Message